Processing....
Latest Federal & Government Contracting Companies' News Coverage
SRI International will provide preclinical treatment development support for the National Cancer Institute’s Prevent Cancer Drug Development Program under a potential $9 million contract. NCI’s Prevent initiative aims to advance the development of biomarkers and drug candidates designed to prevent cancer and transition them from preclinical phase to clinical trials, SRI said Monday. Toufan Parman, […] More
SRI International has announced that it has been awarded a $49 million, seven-year contract with NIH-subsidiary the National Institute of Allergy and Infectious Diseases, to conduct preclinical development of HIV infection and AIDS therapies. The contract will support investigation into drug development and treatment of HIV and AIDS, as well as providing preventive techniques of sexually […] More
Enter your account data and we will send you a link to reset your password.
To use social login you have to agree with the storage and handling of your data by this website.
Accept